2Philpott H, Kette F, Hissaria P, et al. Chronic urticaria: the autoimmune paradigm. Intern Med J, 2008, 38( 11 ): 852-857.
3Novak N. New insights into the mechanism and management of allergic diseases: atopic dermatitis. Allergy, 2009, 64 (2): 265-275.
4Bonness S, Bieber T. Molecular basis of atopic dermatitis. Curr Opin Allergy Clin Immunol, 2007, 7(5): 382-386.
5de Bruin A, Mailer E, Wyder M, et al. Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. J Am Acad Dermatol, 1999, 40(5 Pt 1): 682-685.
6Jessop S, Khumalo NP. Pemphigus: a treatment update. Am J Clin Dermatol, 2008, 9(3): 147-154.
7Errnarm J, Bermas BL. The biology behind the new therapies for SLE. Int J Clin Pract, 2007, 61(12): 2113-2119.
8Koutouzov S, Mathian A, Dalloul A. Type-I interferons and systemic lupus erythematosus. Autoimmun Rev, 2006, 5 (8): 554-562.
9Hausermarm P, Walter RB, Halter J, et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology, 2008, 216(4): 287-304.
10Ferrara JL. Novel strategies for the treatment and diagnosis of graft- versus-host-disease. Best Pratt Res Clin Haematol, 2007, 20( 1 ): 91-97.
